Was Alois Alzheimer Right or Wrong?

Why senile dementia was misclassified as "Alzheimer's disease," and how it confused the field.

Written byMing Chen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In 1907, Aloysius "Alois" Alzheimer presented a rare case of dementia in a 51-year-old woman. This "presenile dementia" (younger than 60) was thought distinct enough from "senile dementia" (older than 65) to warrant a new name, thus it became known as, "Alzheimer's disease" (AD).

In the 1970s, however, some researchers argued that because of their similar symptoms and diagnostic hallmarks, "Alzheimer disease and senile dementia should be considered a single disease."1 This would mean that Alzheimer was wrong. Since then, AD research has been directed at finding a pathogenic cause, be it genetic, metabolic, toxic, or some other causative factor. But after 30 years, while the cause for presenile dementia, or early-onset familial AD, has been essentially found in the form of three mutant genes, the cause for senile dementia, or late-onset sporadic AD, remains unknown.2 Perhaps Alzheimer was right, after all.

Consider other diseases with onset at both middle ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies